Deep Dive #1-2023: Johnson & Johnson

Johnson & Johnson has been a rock for dividend investors for many years

To begin, I would like to thank you for being a premium subscriber to the #1 dividend newsletter on Substack. I do not take your support lightly and hope that you find these deep dive reports useful, as I put hours into research and preparing these documents.

In the attachment below, you will find my first Deep Dive of 2023 covering the health care giant Johnson & Johnson (JNJ).